Scott Rocklage: Investor, Leader, and Researcher

Dr. Scott Rocklage is a medical researcher and business executive. Rocklage has more than two decades of experience in the health sector. Rocklage has held many executive positions over the years. Rocklage holds a Bachelor’s degree in Chemistry from the University of California, Berkeley. He graduated with a Ph.D. in Chemistry from the Massachusetts Institute of Technology. Rocklage conducted his research under Richard Schrock who is a Nobel Prize winner.

 

Scott is considered to be an inventor. He holds several patents to his name. Scott Rocklage has written more than a hundred papers that have appeared in peer-reviewed publications. His leadership resulted in the approval of several drugs including Teslascan and Omniscan by the Food and Drugs Administration. He has taken six other drugs to the clinical trial stage. Rocklage was the chairman of Miikana and Ilypsa that were acquired by Entremed and Amgen respectively.

 

Scott became a venture partner at 5AM Ventures in 2003. Rocklage was named a managing partner at the firm a year later. The venture capital firm invests in early stage companies that operate in the field of biology. Scott is the chairman of the boards of Novira Therapeutics and Cidara Therapeutics. He is also a board member of Pulmatrix, Epirus, Rennovia, and Kinestral. Rocklage is currently based in Massachusetts at one of the offices of 5AM Ventures.

 

Rocklage was interviewed on Ideamensch and gave a few pieces of advice to entrepreneurs and leaders. He said that he does not have a typical day because the activities vary each day. Rocklage explained that he brought ideas to reality by collaborating with entrepreneurs, scientists, and physicians to develop innovative medicine.

 

Rocklage added that his ability to stay organized is what has made him more productive as an entrepreneur. He stated that developments in cancer treatment were one trend that was very exciting for him because of the possibilities in the future. He advised entrepreneurs to embrace risk-taking because it was better than working for an established company. He finished by mentioning that the strategy that had helped him to grow his business was the awareness of the strengths of the business.


No Comments (yet)

Leave a Reply

Comments RSS Subscribe to the Comments RSS.